Gå til indhold
FORSIDEN | LÆS OP | REN TEKST | PRINT | SITEMAP |
Header

Anders Kr. Møller Jakobsen

Anders Jakobsen   

Professor, Forskningsansvarlig

Overlæge, dr.med. Anders Kr. Møller Jakobsen
Onkologisk afdeling, Vejle Sygehus

Center of Clinical Excellence, Sygehus Lillebælt 

E-mail: Anders.Jakobsen@rsyd.dk                      

 

Uddannelse


  • Authorized general practitioner, 1976
  • Authorized specialist in clinical oncology, 1981
  • Doctor of Medical Science, University of Aarhus, 1985
  • Associate professor, University of Aarhus, 1987
  • Professor, University of Southern Denmark, 2001-
     

Ansvarsområder


  • Leder af Klinisk Forskningsenhed, Onkologisk Afdeling
  • Leder af Syddansk Colorectal Cancer Center (Center of Clinical Excellence)
  • Formand for Forskningsrådet SLB
  • Vejledning af PhD-studerende i Onkologisk Afdeling
     

Nuværende projekter og udviklingsaktiviteter


PhD-projekter (hovedvejleder)

  • ­Den kliniske betydning af miRNA ved cancer recti, Anne Mellergaard, afhandling forsvares forår 2018.
  • ­Den kliniske betydning af RAS og RAF mutationer ved coloncancer, Caroline Brenner Thomsen, afhandling indleveres ultimo 2018

Protokoller

  • ­Biomarkers in locally advanced rectal cancer related to the effect of preoperative treatment (BioRect)
  • ­Neoadjuvant chemotherapy versus standard treatment in patients with locally advanced colon cancer (NeoCol)
  • ­Plasma methylated DNA as a prognostic marker of minimal residual disease in non-small cell lung cancer (PROMIL)
  • ­Tocotrienol as a nutritional supplement in patients with advanced ovarian cancer (Toco-Ovar)
  • ­Tocotrienol as a nutritional supplement in patients with advanced pulmonal cancer (Toco-Pulm
  • Curative chemoradiation of low rectal cancer. A prospective multicenter observational study (WW2).
     

Afsluttede projekter


PhD-projekter (hovedvejleder)

  • ­Bioeffect modelling of clinical outcomes after radiation therapy for individualization of treatment effect estimation and risk prediction. Ane L Appelt, 2014.
  • ­The clinical importance of quantitative HER2 determination in breast cancer. Troels Bechmann, 2013.
  • ­Plasma KRAS mutations and cell-free DNA in patients with advanced Non Small Cell Lung Cancer. Anneli Dowler Nygaard, 2013.
  • ­Prognostic tissue markers in stage II colon cancer. A population based study. Sanne Kjær-Frifeldt, 2012.
  • ­The Clinical Importance of the Platelet-Derived Growth Factor System in Ovarian Cancer. Christine Vestergaard Madsen, 2012.
  • ­Hypoxia and hypoxia related biomarkers in rectal cancer. Birgitte Mayland Havelund, 2012.
  • ­The Clinical Importance of Vascular Endothelial Growth Factor in Breast Cancer. Else Maae. 2012.
  • The Clinical Importance of VEGF in Epithelial Ovarian Cancer. Maja Patricia Smerdel, 2011.
  • ­The Clinical Importance of the Vascular Endothelial Growth Factor System in Colorectal Cancer. Torben Frøstrup Hansen, 2010.
  • ­The HER Family in Epithelial Ovarian Cancer. Biological and clinical aspects. Karina Dahl Steffensen, 2008.
  • ­Mismatch Repair Deficiency in Colorectal Cancer. Lars Henrik Jensen, 2007.
  • ­The Epidermal Growth Factor Receptor in Colorectal Cancer. Karen-Lise Garm Spindler, 2006.

Udvalg


  • Det Regionale Strategiske Forskningsråd
  • Bedømmelsesudvalg for Region Syddanmarks forskningspulje samt ph.d.- og forskerkarrierepulje
  • Forsknings- og strukturudvalg for Personlig Medicin
  • Videnskabeligt Udvalg under Dansk Colorectal Cancer Gruppe
  • Forretningsudvalg, Dansk Gynækologisk Cancer Gruppe
     

Publikationer og aktiviteter


Se link til Anders Jakobsen's publikationer, aktiviteter m.m. på SDU.dk - link


Siden er sidst opdateret 10-01-2018.
Kontakt: admtda



Sygehus Lillebælt | Telefon 76 36 20 00 | Send sikker e-mail til Sygehus Lillebælt